Jérôme Denard

Title: Innovations by Jérôme Denard in Vector Penetration Efficiency

Introduction

Jérôme Denard is an accomplished inventor based in Choisy le Roi, France. He has made significant contributions to the field of gene therapy, particularly in enhancing the efficiency of vector penetration into target tissues. His innovative methods have the potential to improve therapeutic outcomes for patients receiving viral vector-based treatments.

Latest Patents

Denard holds a patent titled "Methods of increasing efficiency of vector penetration of target tissue." This patent outlines methods for increasing the efficiency of target tissue penetration of an adeno-associated virus (AAV) vector in a patient. The methods involve inhibiting the interaction of the serum protein galectin 3 binding protein (G3BP) with the AAV vector. Additionally, the patent provides methods for reducing tissue distribution of a virus or for neutralizing a virus harbored by an organ destined for transplant, or newly transplanted, by administering a composition comprising G3BP.

Career Highlights

Throughout his career, Jérôme Denard has worked with notable organizations, including the Association Institut De Myologie and Genethon. His work in these institutions has allowed him to collaborate with leading experts in the field of myology and gene therapy, further enhancing his expertise and contributions to the industry.

Collaborations

Denard has collaborated with esteemed colleagues such as Luis Garcia and Thomas Voit. These partnerships have fostered a collaborative environment that promotes innovation and the advancement of research in vector technology.

Conclusion

Jérôme Denard's innovative methods for enhancing vector penetration efficiency represent a significant advancement in gene therapy. His contributions have the potential to improve treatment outcomes for patients and pave the way for future research in this vital area of medicine.